An observational study in Subarachnoid Hemorrhage, Aneurysmal, sponsored by Fujian Medical University. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2012-03-30.
Sponsored by Fujian Medical University · Observational
The purpose of this study is to examine the risk factors for aneurysm rebleeding.
To investigate risk factors for spontaneous aneurysm rebleeding during hospitalization and to reach conclusions if any,of clinical signs for predicting rebleeding.
509 studies on the registry are indexed under Subarachnoid Hemorrhage; 124 are open to participants now.
This study's planned enrollment of 66 is below the median of 117 across 226 observational studies indexed under Subarachnoid Hemorrhage.
Browse Subarachnoid Hemorrhage studies →Fujian Medical University is the lead sponsor of 144 studies on the registry; 49 are open to participants now.
Counted across the registry records on this site, refreshed daily.
A total of 66 SAH patients were enrolled in this study
Exclusion Criteria:
Rebleeding patients with certain inducing factors such as:
with other intracranial vascular malformations,such as:
The case group referred to SAH patients with aneurysm rebleeding
the control group referred to SAH patients not with aneurysm rebleeding
Aneurysm rebleeding
Time frame: up to 7 months
This study is status unknown, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fujian Medical University